Candel Therapeutics Inc (NASDAQ: CADL) on Friday, soared 5.22% from the previous trading day, before settling in for the closing price of $7.85. Within the past 52 weeks, CADL’s price has moved between $1.34 and $14.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -25.00% annually for the last half of the decade. The company achieved an average annual earnings per share of -4.53%. With a float of $32.47 million, this company’s outstanding shares have now reached $44.48 million.
In an organization with 42 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 54.28%, operating margin of -2001.58%, and the pretax margin is -2939.13%.
Candel Therapeutics Inc (CADL) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Candel Therapeutics Inc is 26.98%, while institutional ownership is 36.04%. The most recent insider transaction that took place on Jan 15 ’25, was worth 97,783. In this transaction Chief Scientific Officer of this company sold 13,534 shares at a rate of $7.22, taking the stock ownership to the 110,673 shares. Before that another transaction happened on Jan 15 ’25, when Company’s Chief Technology Officer sold 14,322 for $7.22, making the entire transaction worth $103,476. This insider now owns 96,790 shares in total.
Candel Therapeutics Inc (CADL) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -4.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.88% during the next five years compared to -46.75% drop over the previous five years of trading.
Candel Therapeutics Inc (NASDAQ: CADL) Trading Performance Indicators
Candel Therapeutics Inc (CADL) is currently performing well based on its current performance indicators. A quick ratio of 1.18 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.74, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -1.03 in one year’s time.
Technical Analysis of Candel Therapeutics Inc (CADL)
Let’s dig in a bit further. During the last 5-days, its volume was 0.88 million. That was inferior than the volume of 1.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 17.01%. Additionally, its Average True Range was 0.95.
During the past 100 days, Candel Therapeutics Inc’s (CADL) raw stochastic average was set at 41.38%, which indicates a significant increase from 15.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 156.03% in the past 14 days, which was lower than the 160.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.31, while its 200-day Moving Average is $6.79. However, in the short run, Candel Therapeutics Inc’s stock first resistance to watch stands at $8.47. Second resistance stands at $8.68. The third major resistance level sits at $9.02. If the price goes on to break the first support level at $7.92, it is likely to go to the next support level at $7.57. The third support level lies at $7.36 if the price breaches the second support level.
Candel Therapeutics Inc (NASDAQ: CADL) Key Stats
Market capitalization of the company is 367.37 million based on 32,476K outstanding shares. Right now, sales total 0 K and income totals -37,940 K. The company made 0 K in profit during its latest quarter, and -10,650 K in sales during its previous quarter.
